Showing results (181-190 of 232) with videos related to

Sort By:
Pageof 24
Disease Markers|October 1, 2019
Proteomic Comparison of Malignant Human Germ Cell Tumor Cell LinesFelix Bremmer, Hanibal Bohnenberger, Stefan Küffer, et al.
Molecular Cancer Therapeutics|March 12, 2009
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancerMarcus M Schittenhelm, Christian Kollmannsberger, Karin Oechsle, et al.
The Journal of Pathology|July 2, 2010
Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistanceHendrik Wermann, Hans Stoop, Ad J M Gillis, et al.
Proteomics|April 27, 2017
Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalininSergey A Dyshlovoy, Katharina Otte, Simone Venz, et al.
Bjpsych Open|December 14, 2020
A mechanism-based group-psychotherapy approach to aggressive behaviour in borderline personality disorder: findings from a cluster-randomised controlled trialS C Herpertz, B Matzke, K Hillmann, et al.
Plos Pathogens|December 22, 2023
Genes differentially expressed between pathogenic and non-pathogenic Entamoeba histolytica clones influence pathogenicity-associated phenotypes by multiple mechanismsJuliett Anders, Constantin König, Corinna Lender, et al.
Human Pathology|December 20, 2005
Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumorsMartine Cools, Friedemann Honecker, Hans Stoop, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2003
Superoxo, mu-peroxo, and mu-oxo complexes from heme/O2 and heme-Cu/O2 reactivity: copper ligand influences in cytochrome c oxidase modelsEunsuk Kim, Matthew E Helton, Ian M Wasser, et al.
Biology of Sex Differences|April 5, 2026
Sex shapes CD64 expression and vaccine-induced monocytic responsesCharlotte Sophie Hansen, Julie Sellau, Anastasia Langanz, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2021
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumorsVera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, et al.
Pageof 24